InsiderClue
Insiders · Profile

Li Dean Y

Executive VP & President, MRL at Merck · Director at RECURSION PHARMACEUTICALS. Filing since 17 Nov 2021. CIK 0001837016

MRK Merck & Co. Executive VP & President, MRL · 3 trades RXRX RECURSION PHARMACEUTICALS, INC. Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
MRK Merck & Co.
10 Feb 2026
Executive VP & President, MRL
Sold at will
10,235
$1.20M
10.0%
MRK Merck & Co.
4 Feb 2026
Executive VP & President, MRL
Sold at will
15,087
$1.79M
12.9%
MRK Merck & Co.
9 Feb 2024
Executive VP & President, MRL
Sold at will
14,702
$1.85M
24.1%
RXRX RECURSION PHARMACEUTICALS, INC.
9 Jan 2024
Director
Sold on a plan
29,000
$396.21K
6.4%
RXRX RECURSION PHARMACEUTICALS, INC.
7 Dec 2021
Director
Sold, plan not stated
15,900
$325.63K
1.2%
RXRX RECURSION PHARMACEUTICALS, INC.
19 Nov 2021
Director
Sold, plan not stated
13,474
$272.23K
2.3%
RXRX RECURSION PHARMACEUTICALS, INC.
17 Nov 2021
Director
Sold, plan not stated
5,626
$112.74K
0.9%
7 decisions on file.